A phase I/II clinical trial of modified vaccinia virus Ankara (MVA) [TBC-MVA; smallpox vaccine; Therion Biologics] to evaluate its safety, dosing schedule, immunogenicity and protective efficacy against Dryvax [smallpox vaccine] challenge in vaccinia-naive individuals
Phase of Trial: Phase I/II
Latest Information Update: 09 Feb 2007
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Adverse reactions
- 09 Feb 2007 Results have been reported.
- 19 Nov 2006 New trial record.